Kamakshiammal Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -29.90%
(FY 2022)
- Profit -110.78%
(FY 2022)
- Ebitda -25.21%
(FY 2022)
- Net Worth -3.29%
(FY 2022)
- Total Assets -7.42%
(FY 2022)
About Kamakshiammal Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vijaykumaran Dwarakanathan and Muthusamy Swaminathan serve as directors at the Company.
- CIN/LLPIN
U33100TN2018PTC122910
- Company No.
122910
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruchirappalli, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kamakshiammal Diagnostics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijaykumaran Dwarakanathan  | Director | 23-Nov-2018 | Current |
| Muthusamy Swaminathan | Additional Director | 15-Dec-2021 | Current |
Financial Performance of Kamakshiammal Diagnostics.
Kamakshiammal Diagnostics Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 29.9% decrease. The company also saw a substantial fall in profitability, with a 110.78% decrease in profit. The company's net worth dipped by a decrease of 3.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kamakshiammal Diagnostics?
In 2021, Kamakshiammal Diagnostics had a public holding of 99.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kallal Pettigo Holdings Private LimitedActive 3 years 9 monthsVijaykumaran Dwarakanathan is a mutual person
Kallal Logistics Private LimitedActive 3 years 10 monthsVijaykumaran Dwarakanathan is a mutual person
- Glazebrooke Trading Private LimitedActive 7 years 1 month
Vijaykumaran Dwarakanathan is a mutual person
- Tharana Healthcare Private LimitedActive 6 years 7 months
Vijaykumaran Dwarakanathan and Muthusamy Swaminathan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kamakshiammal Diagnostics?
Unlock and access historical data on people associated with Kamakshiammal Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kamakshiammal Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kamakshiammal Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
